Molnupiravir Capsule — FDA Drug Shortage

To Be Discontinued — Merck Sharp & Dohme LLC

The FDA lists a drug shortage record for Molnupiravir Capsule (capsule) from Merck Sharp & Dohme LLC with status To Be Discontinued. The shortage was first posted on Oct 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Merck Sharp & Dohme LLC
Package NDC
0006-5055-06
Dosage Form
Capsule
Presentation
Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)
Initial Posting
Oct 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.